Related Experiment Video
Updated: Jun 5, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
What Nephrologists Should Know About Infection Prevention Measures Before and During Eculizumab Administration in
1Research Center of Pediatric Infectious Diseases, Institute of Immunology and Infectious Diseases, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Insights
Children on eculizumab (a terminal complement inhibitor) face high infection risks, especially from meningococcal disease. Vaccination and antibiotic prophylaxis are crucial for preventing serious infections in these pediatric patients.
Area of Science:
- Immunology
- Pharmacology
- Pediatrics
Background:
- Eculizumab is a monoclonal antibody inhibiting the terminal complement pathway (C5b-9).
- It's used in Iran for various adult and pediatric conditions.
- Patients on eculizumab have increased risk of life-threatening infections, notably meningococcal disease.
Purpose of the Study:
- To address pediatric nephrologists' questions on vaccination changes for children receiving eculizumab.
- To discuss increased infection risks and emphasize preventive measures.
- To provide updated recommendations for infection prevention during eculizumab treatment.
Main Methods:
- Review of current literature and clinical guidelines.
- Focus on infection prevention strategies for pediatric patients.
- Analysis of eculizumab's mechanism and associated risks.
Main Results:
- Children on eculizumab require specific vaccination, including the meningococcal vaccine.
- Combined vaccination and prophylactic antibiotic use is the most effective prevention strategy.
- Antibiotic prophylaxis should commence with eculizumab and continue post-treatment.
Conclusions:
- Routine vaccination schedules may need modification for children on eculizumab.
- Proactive infection prevention, including vaccination and antibiotics, is essential.
- Adherence to updated guidelines ensures optimal patient safety during eculizumab therapy.
Abstract:
Eculizumab is a recombinant humanized monoclonal antibody that acts as a terminal complement inhibitor. It works by binding to complement protein 5 and inhibiting its cleavage, thereby preventing the production of the complement terminal complex known as C5b-9. Eculizumab has been prescribed by physicians in Iran in both the adult and pediatric fields for the treatment of various diseases. Patients who receive this product are at an increased risk of life-threatening infections, with meningococcal disease being one of the most prevalent threats. Therefore, children receiving eculizumab, should receive meningococcal vaccine. Furthermore, the most effective method to prevent infection in these patients is a combination of vaccination and prophylactic antibiotic usage. Antibiotic prophylaxis should be initiated immediately after the initiation of eculizumab and continued for four weeks after discontinuation of the drug. This review aims to address physicians' questions particularly pediatric nephrologists regarding any necessary changes in routine vaccinations for children receiving eculizumab. Additionally, the article discusses infections that may occur more frequently in this population and emphasizes the importance of vaccination and preventive measures. The review also aims to introduce the most up- to- date recommendations for infection prevention before and during eculizumab treatment.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome III : Nursing Management
Kidney Transplant III: Nursing Management
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...